Obesity Clinical Trial
— SPA-VROfficial title:
Development and Impact of a Virtual Reality Exposure Intervention on Social Physical Anxiety During Physical Activity in Women With Obesity
NCT number | NCT04630184 |
Other study ID # | |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | September 1, 2021 |
Est. completion date | December 31, 2023 |
The objectives of the project are to: i) assess the feasibility and acceptability of the protocol and the VR exposure intervention in women with obesity, and ii) obtain an estimate of the effect of VR exposure intervention associated with an exercise training on SPA, compliance, adherence and persistence to the exercise training, as well as persistence in PA practice in the middle term to calculate the sample size for a future larger randomized controlled trial (RCT) in women with obesity. A RCT of feasibility will be carried out. Forty-five women with obesity and a high level of SPA will be randomized into one of the following three groups: 1) Exercice and VR exposure (Ex + expo), 2) Exercise and psychological intervention control (Ex + control) or 3) waiting list (WL). The interventions will have a physical exercise training (identical for all) and a psychology intervention (different according to the condition: VR exposure or control). The feasibility and acceptability of the protocol and the VR exposure intervention will be assessed at the end of the study. SPA, PA practice, anthropometry, internalization of weight bias, body appreciation, perceived pleasure, motivational regulation, self-efficacy, affects as well as perception effort will be evaluated with questionnaires and scales validated before and after the intervention and 6 months after the end of the intervention. Sociodemographic data, depressive symptoms, problematic eating behaviors and propensity to immersion will be assessed during the initial visit only. Adherence, adherence and persistence to the PA program will be calculated at the end of the intervention. Persistence in PA practice will be calculated using data collected immediately after the end of the intervention and 6 months after the intervention.
Status | Recruiting |
Enrollment | 45 |
Est. completion date | December 31, 2023 |
Est. primary completion date | March 31, 2023 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 45 Years |
Eligibility | Inclusion Criteria: - woman - inactive (<150 min. of moderate to vigorous PA / week ) - aged between 18 and 45 years - BMI = 30 kg / m2 - to be able to go to Université du Québec en Outaouais twice a week Exclusion Criteria: - to have a low to moderate social physical anxiety level (SPA score <27/45 on the physical and social anxiety scale ) - suffer from hypersensitivity to motion sickness - to be pregnant or plan to become over the next year - to take medication that may influence weight - to have undergone bariatric surgery - to have a contraindication to physical activity - to have participated in a physical activity program in the last 6 months supervised - to have an intellectual disability, and have a severe and persistent psychiatric problem (psychosis, bipolar disorder). |
Country | Name | City | State |
---|---|---|---|
Canada | UQO | Gatineau | Quebec |
Lead Sponsor | Collaborator |
---|---|
Universite du Quebec en Outaouais |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Propensity to immersion | Validated questionnaire | Before the intervention (baseline) | |
Other | The feeling of presence in immersion the feeling of presence in immersion | Gatineau presence questionnaire | after each virtual reality session (weeks 1, 2, 3, 4, 5,6 , 9 amd 12) | |
Other | Cybermalaise | Simulator Sickness Questionnaire | before and after each virtual reality session (weeks 1, 2, 3, 4, 5,6 , 9 amd 12) | |
Other | Sociodemographic data | age, sex,ethnocultural group, level of education, professional status | before the intervention (baseline) | |
Other | Depressive symptoms | Center Epidémiologic Scale-Depression-French ; scale (0-3) score range (0-60) higher score = higher depressive symptoms | before the intervention (baseline) | |
Other | Food disorder | Eating Attitudes Test-26 ; scale (0-3) score range (0-78), Higher scores indicating greater risk of an eating disorder | before the intervention (baseline) | |
Other | Weight Bias Internalisation change (0-12 weeks) | Modified Weight Bias Internalisation Scale, scale (1-7), range score (11-77), higher score = higher Weight Bias Internalization) | Before and after intervention (Baseline and after 12 weeks) | |
Other | Body composition change (0-12 weeks) | bio-impedance balance (Tanita MC 780U) made by research assistant | Before and after intervention (Baseline and after 12 weeks) | |
Other | Body index mass change (0-12 weeks) | scale and measuring rod to measure the size made by research assistant | Before and after intervention (Baseline and after 12 weeks) | |
Other | Waist circumference change (0-12 weeks) | tape measure made by research assistant | Before and after intervention (Baseline and after 12 weeks) | |
Other | Body Appreciation change (0-12 weeks) | Body Appreciation Scale-2, scale (1-5) score range (1-5), higher score = higher body satisfaction | Before and after intervention (Baseline and after 12 weeks) | |
Other | Perceived pleasure in physical activity in general (0-12 weeks) | Physical Activity Enjoyment Scale, scale (1-7) score (1-7) higher score = higher enjoyment | Before and after intervention (Baseline and after 12 weeks) | |
Other | Motivation change (0-12 weeks) | Behavioural Regulation In Exercise Questionnaire, scale (0-4), Higher, positive scores indicate greater relative autonomy; lower, negative scores indicate more controlled regulation. | Before and after intervention (Baseline and after 12 weeks) | |
Other | Affects during exercise change (0-12 weeks) | Felt Arousal Scale (score 1-6) higher score = higher felt arousal + Feeling Scale (score -5,5) higher score higher pleasure | Before and after intervention (Baseline and after 12 weeks) | |
Other | Self-efficacy change (0-12 weeks) | Self efficacy scale (Bandura), scale (0-100) score range (0-100) higher score = higher self efficacy | Before and after intervention (Baseline and after 12 weeks) | |
Other | Perception effort change (0-12 weeks) | Borg scale, scale and score range (0-10), higher score = higher perception of effort | Before and after intervention (Baseline and after 12 weeks) | |
Primary | Feasibility of the protocol and the intervention | The feasibility of the protocol will be assessed at the end of the study using the following criteria: i) the recruitment rate (number of participants recruited per month), ii) the retention rate (number of participants who have completed all the assessments and focus group and reason for dropout), iii) percentage of missing data (number of missing data out of number of total data) and iv) acceptance of randomization.
The feasibility of the intervention will be evaluated at the end of the study using the following criteria: v) the participation rate (number of eligible participants who agreed to participate in the study), vi) the participation rate adherence (number of participants who completed the 8 psychological intervention sessions), vii) the attrition rate (number of participants who abandoned the psychological intervention and reasons). The achievement of the following criteria will be considered as a success factor in terms of feasibility (14, 23): i) recruitment rate = 5.6, |
At the end of the study (+ 36 weeks) | |
Primary | Acceptability of the protocol and the intervention | The acceptability of the protocol and the intervention will be qualitatively assessed through 5 to 7 semi-structured discussion groups by teleconference via the zoom platform. The participants will be interviewed for 75 minutes in sub-groups of 6 to 8 participants on their perception, opinion and experience regarding the intervention and the implementation of the protocol (barriers, facilitators, satisfaction, perceived benefits, recommendation and improvement). An interview guide constructed for the purpose of the study will ensure consistency of the themes explored between the different groups while guiding the group facilitation. | At the end of the intervention (+ 12 weeks) | |
Secondary | Social physical anxiety change (0-12 weeks) | Social physical anxiety scale (validated questionnaire) | Before and after intervention (Baseline and after 12 weeks) | |
Secondary | Adherence to the physical activity (PA) intervention | Adherence to the PA intervention will be calculated as a percentage from the total number of sessions performed out of the 36 prescribed sessions (frequency). | At the end of the PA intervention (after 12 weeks) | |
Secondary | Compliance with the PA intervention | Compliance with the PA intervention will be calculated as a percentage from the number of sessions for which the participant will have prescribed the prescription compared to all sessions. For these calculations, data from heart rate monitors worn by participants during PA sessions and diaries completed by participants and the kinesiologist will be used. | At the end of the PA intervention (after 12 weeks) | |
Secondary | Physical activity change (0-12 weeks) | Triaxial accelerometer (Actigraph® wGT3X-BT) worn on the hip for 7 days | Before and after intervention (Baseline and after 12 weeks) | |
Secondary | Persistance in the practice of PA after the intervention | Triaxial accelerometer (Actigraph® wGT3X-BT) worn on the hip for 7 days | Immediately after the intervention and at the end of the study (after 12 weeks and 36 weeks) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |